ARS Pharmaceuticals, Inc.SPRYNASDAQ
Loading
Debt-to-equity ratio
3Y CAGR
+683.8%/yr
vs -74.6%/yr prior
Acceleration
+758.4pp
Accelerating
Percentile
P100
Near historical high
vs 3Y Ago
481.4x
Strong expansion
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.85 | +518768.5% |
| 2024 | 0.00 | -86.2% |
| 2023 | 0.00 | -32.6% |
| 2022 | 0.00 | +100.6% |
| 2021 | -0.29 | +59.5% |
| 2020 | -0.71 | +74.4% |
| 2019 | -2.79 | -755.9% |
| 2018 | 0.43 | - |